Literature DB >> 21511414

Endothelial progenitor cells, bronchopulmonary dysplasia and other short-term outcomes of extremely preterm birth.

Giulia Paviotti1, Gian Paolo Fadini, Elisa Boscaro, Carlo Agostini, Angelo Avogaro, Lino Chiandetti, Eugenio Baraldi, Marco Filippone.   

Abstract

AIM: To evaluate the impact of endothelial progenitor cells (EPCs), a subset of committed circulatory stem cells, on the development of bronchopulmonary dysplasia (BPD) and other short term outcomes in a cohort of extremely premature newborns.
METHODS: Progenitor cells were quantified by flow cytometry at birth in 36 neonates born <=28 weeks of gestation and at 36 postmenstrual weeks in 18 of them. Cells expressing the stemness markers CD34, CD133, or both were defined as circulating progenitor cells (CPCs). EPCs were defined as CPCs co-expressing the endothelial marker KDR.
RESULTS: Mean (SD) gestational age and birth weight of the infants studied were 26.2(1.5) weeks and 761.6(171.8) grams, respectively. EPC levels at birth did not differ between infants who subsequently developed BPD (n=9) and those who did not (n=24) [CD34(+)KDR(+) EPCs: 81(34-41) vs 80(56-110), p=0.7] and were not correlated with the duration of mechanical ventilation or O2-dependence, nor with the need of surfactant replacement. Infants with a hemodynamically significant patent ductus arteriosus (PDA) (n=22) had significantly lower EPC levels at birth than those with no PDA (n=11) [CD34(+)KDR(+) cells: 47(34-92) vs 142(84.5-221), p=0.008]. Data from the 18 infants studied both at birth and at 36 postmenstrual weeks showed that, while CPCs sharply decline over time, levels of all EPCs phenotypes are preserved after delivery.
CONCLUSIONS: Levels of EPCs at birth did not affect the risk of developing BPD in our group of extremely premature neonates. However, the association between low EPC counts at birth and PDA may be clinically relevant, and deserves further studies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21511414     DOI: 10.1016/j.earlhumdev.2011.03.011

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  12 in total

1.  Mobilization of circulating progenitor cells following brain injury in premature neonates could be indicative of an endogenous repair process. A pilot study.

Authors:  N Efstathiou; V Soubasi; G Koliakos; G Kyriazis; D I Zafeiriou; A Slavakis; K Kantziou; T Pozotou; O Chatzizisi; V Drosou-Agakidou
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

Review 2.  The Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series).

Authors:  Steven H Abman; Christopher Baker; Jason Gien; Peter Mourani; Csaba Galambos
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

3.  Lung parenchymal development in premature infants without bronchopulmonary dysplasia.

Authors:  Santiago J Assaf; Daniel V Chang; Christina J Tiller; Jeffrey A Kisling; Jamie Case; Julie A Mund; James E Slaven; Zhangsheng Yu; Shawn K Ahlfeld; Brenda Poindexter; Laura S Haneline; David A Ingram; Robert S Tepper
Journal:  Pediatr Pulmonol       Date:  2014-12-02

4.  Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia.

Authors:  Christopher D Baker; Vivek Balasubramaniam; Peter M Mourani; Marci K Sontag; Claudine P Black; Sharon L Ryan; Steven H Abman
Journal:  Eur Respir J       Date:  2012-04-10       Impact factor: 16.671

5.  Increased circulating endothelial progenitor cells (EPCs) in prepubertal children born prematurely: a possible link between prematurity and cardiovascular risk.

Authors:  Panagiota Markopoulou; Eleni Papanikolaou; Sofia Loukopoulou; Paraskevi Galina; Aimilia Mantzou; Tania Siahanidou
Journal:  Pediatr Res       Date:  2020-10-10       Impact factor: 3.756

6.  Circulating hematopoietic and endothelial progenitor cells in newborn infants: effects of gestational age, postnatal age and clinical stress in the first 3 weeks of life.

Authors:  Kim Chi T Bui; Mark Weems; Manoj Biniwale; Aswathi A George; Ewa Zielinska; Colleen G Azen; Manuel Durand; Hisham Abdel-Azim
Journal:  Early Hum Dev       Date:  2013-01-09       Impact factor: 2.079

Review 7.  Stem cell therapy for neonatal diseases associated with preterm birth.

Authors:  Alessandro Borghesi; Claudia Cova; Diego Gazzolo; Mauro Stronati
Journal:  J Clin Neonatol       Date:  2013-01

8.  Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns.

Authors:  Maciej Kotowski; Krzysztof Safranow; Miłosz P Kawa; Joanna Lewandowska; Patrycja Kłos; Violetta Dziedziejko; Edyta Paczkowska; Ryszard Czajka; Zbigniew Celewicz; Jacek Rudnicki; Bogusław Machaliński
Journal:  BMC Pediatr       Date:  2012-09-17       Impact factor: 2.125

9.  Circulating endothelial progenitor cells decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide.

Authors:  Yuanyuan Qi; Qian Jiang; Chao Chen; Yun Cao; Liling Qian
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

Review 10.  Endogenous and Exogenous Stem/Progenitor Cells in the Lung and Their Role in the Pathogenesis and Treatment of Pediatric Lung Disease.

Authors:  Sandra Leibel; Martin Post
Journal:  Front Pediatr       Date:  2016-04-14       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.